The Iowa orthopaedic journal

Did Quickly Increasing Same-Day Hip and Knee Replacements During COVID-19 Lead to More Early Problems?

GLP-1 Therapies Weekly Brief ↗PubMed ↗

Updated

Abstract

A total of 14,438 patients underwent total knee arthroplasty (TKA) and 12,265 patients underwent total hip arthroplasty (THA) during the study period.

  • No significant difference in total complication rates was observed for TKA between pre-COVID (3.55%) and post-COVID (3.99%) groups.
  • Rates of readmissions for TKA were similar in pre-COVID (1.75%) and post-COVID (1.98%) groups.
  • There was a statistically significant decrease in respiratory complications for TKA in the post-COVID group (0.23%) compared to pre-COVID (0.41%).
  • For THA, total complication rates did not differ significantly between pre-COVID (3.25%) and post-COVID (3.49%) groups.
  • Readmission rates for THA were comparable in pre-COVID (1.77%) and post-COVID (1.68%) groups.
  • A decrease in combined respiratory complications was noted in the post-COVID group (0.15% vs. 0.30%).

Simplified

Funding

Competing interests

Disclosures: The authors report no potential conflicts of interest related to this study.
PubMed

Related papers

Nov '21
Same-Day Discharge After Hip and Knee Replacement: Patterns, Complications, and Hospital Return Rates
top 5% journal
cited by 66 papers
journal article
Sep '16
Leaving the hospital within 2 days after hip or knee replacement does not raise major complications or readmission rates
cited by 122 papers
journal article
May '19
Is having hip and knee replacement surgery together during one hospital stay safe?
top 5% journal
cited by 11 papers
journal article
Jun '19
Factors linked to hospital stay length, discharge place, and 30-day readmission after first hip or knee replacement
top 10% journal
cited by 128 papers
journal article
Nov '17
Readmission, Reoperation, and Complications After Total Hip Compared to Total Knee Replacement
top 5% journal
cited by 56 papers
journal article

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #59
GLP-1 drugs linked to fewer psychiatric hospitalizations in schizophrenia patients with diabetes
2 weeks ago7 studies
issue #58
A new triple receptor drug cut body weight by nearly 20% in 24 weeks
3 weeks ago7 studies
issue #57
A triple-receptor obesity drug just posted 25–35% weight loss in a phase 3 trial
4 weeks ago7 studies
issue #56
Semaglutide cut heart attack risk by 20% — but weight loss explains less than half of it
5 weeks ago7 studies
issue #55
The brain circuit that makes GLP-1 drugs work also causes nausea — and they can't be separated
6 weeks ago7 studies
issue #54
GLP-1 drugs don't build habits — and that gap is costing patients their results
7 weeks ago7 studies
issue #53
Semaglutide slowed aging and extended lifespan in older female mice
8 weeks ago7 studies
issue #52
GLP-1 drugs linked to lower Parkinson's risk in people with type 2 diabetes
9 weeks ago7 studies
issue #51
Semaglutide linked to nearly double the risk of a rare eye condition in people with diabetes
10 weeks ago7 studies
issue #50
A once-daily pill beat placebo on weight loss — and it wasn't semaglutide
11 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief